Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002401304 | SCV002708814 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-08-11 | criteria provided, single submitter | clinical testing | The p.V544G variant (also known as c.1631T>G), located in coding exon 10 of the PDGFRA gene, results from a T to G substitution at nucleotide position 1631. The valine at codon 544 is replaced by glycine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003475370 | SCV004200980 | uncertain significance | Polyps, multiple and recurrent inflammatory fibroid, gastrointestinal | 2023-05-05 | criteria provided, single submitter | clinical testing |